Fingerprint
Dive into the research topics of 'Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
Thomas B. Hakes, Eva Chalas, William J. Hoskins, Walter B. Jones, Maurie Markman, Stephen C. Rubin, Douglas Chapman, Lois Almadrones, John L. Lewis
- Memorial Sloan-Kettering Cancer Center
- Stony Brook University
- Gynecology Service
- University of Arizona
- Division of Solid Tumor Oncology
- Section of Hematology/Oncology
- Department of Medicine
- Division of Solid I amor Oncology
- Cornell University
- Pfizer
- Cleveland Clinic Foundation
- University of Pennsylvania
- Nuclear Medicine Service
- Department of Medicine
- University of Texas MD Anderson Cancer Center
- New York-Downtown Hospital
- Departments of Anesthesiology and Critical Care Medicine
- Division of Biostatistics and Epidemiology
- University of Texas Health Science Center at Houston
- Department of Epidemiology and Biostatistics
Research output: Contribution to journal › Article › peer-review
153
Scopus
citations